featured
Everolimus Plus Aromatase Inhibitors as Maintenance Therapy After First-Line Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Everolimus Plus Aromatase Inhibitors as Maintenance Therapy After First-Line Chemotherapy: Final Results of the Phase III Randomised MAIN-A (MAINtenance Afinitor) Trial
Eur. J. Cancer 2021 Sep 01;154(xx)21-29, V Guarneri, CA Giorgi, S Cinieri, C Bengala, G Mariani, G Bisagni, A Frassoldati, C Zamagni, C De Rossi, V Amoroso, C Andreetta, A Ferro, A Zambelli, S Gori, O Garrone, MV Dieci, L Orlando, I Pastina, T Beninato, G Moretti, E Genovesi, M Cinefra, R Vicini, G Magni, GL De Salvo, P ConteFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.